Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Type 1 Diabetes and Bone Fragility: Links and Risks.

Starup-Linde J, Hygum K, Harsløf T, Langdahl B.

Diabetes Metab Syndr Obes. 2019 Dec 3;12:2539-2547. doi: 10.2147/DMSO.S191091. eCollection 2019. Review.

2.

Primary hyperparathyroidism and recurrent ventricular tachyarrhythmia in a patient with novel RyR2 variant but without structural heart disease.

Pedersen CM, Rolighed L, Harsløf T, Jensen HK, Nielsen JC.

Clin Case Rep. 2019 Aug 23;7(10):1907-1912. doi: 10.1002/ccr3.2363. eCollection 2019 Oct.

3.

The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes.

Hygum K, Starup-Linde JK, Harsløf T, Joergensen NR, Hartmann B, Holst JJ, Langdahl B.

Eur J Endocrinol. 2019 Jun 1. pii: EJE-19-0309.R1. doi: 10.1530/EJE-19-0309. [Epub ahead of print]

PMID:
31189129
4.

Current Status of Bone-Forming Therapies for the Management of Osteoporosis.

Sølling ASK, Harsløf T, Langdahl B.

Drugs Aging. 2019 Jul;36(7):625-638. doi: 10.1007/s40266-019-00675-8. Review.

PMID:
31066015
5.

T-score differences and nonprogression in lumbar vertebrae as predictors of vertebral fractures.

Lajlev SE, Rejnmark L, Harsløf T.

Clin Endocrinol (Oxf). 2019 Jul;91(1):58-62. doi: 10.1111/cen.13987. Epub 2019 Apr 23.

PMID:
30973641
6.

Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review.

Harsløf T, Rolighed L, Rejnmark L.

Endocrine. 2019 Apr;64(1):176-183. doi: 10.1007/s12020-019-01858-4. Epub 2019 Feb 20.

PMID:
30788669
7.

[Phytoestrogens as a dietary supplement].

Olsen A, Kyrø C, Schwarz P, Vestergaard P, Lidegaard Ø, Hermann P, Langdahl B, Beck Jensen JE, Abrahamsen B, Harsløf T.

Ugeskr Laeger. 2018 Dec 3;180(49). pii: V04180286. Danish.

PMID:
30520719
8.

The dental perspective on osteogenesis imperfecta in a Danish adult population.

Thuesen KJ, Gjørup H, Hald JD, Schmidt M, Harsløf T, Langdahl B, Haubek D.

BMC Oral Health. 2018 Oct 24;18(1):175. doi: 10.1186/s12903-018-0639-7.

9.

[Examination for osteoporosis in patients with chronic obstructive pulmonary disease].

Johansen NJ, Harsløf T, Hermann AP, Andersen CU, Hilberg O, Løkke A.

Ugeskr Laeger. 2018 Oct 1;180(40). pii: V12170934. Danish.

PMID:
30274583
10.

The clinical potential of romosozumab for the prevention of fractures in postmenopausal women with osteoporosis.

Sølling ASK, Harsløf T, Langdahl B.

Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):105-115. doi: 10.1177/1759720X18775936. Epub 2018 Jun 7. Review.

11.

Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control Study.

Ejlsmark-Svensson H, Bislev LS, Lajlev S, Harsløf T, Rolighed L, Sikjaer T, Rejnmark L.

J Bone Miner Res. 2018 Sep;33(9):1657-1664. doi: 10.1002/jbmr.3461. Epub 2018 Jun 7.

12.

Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series.

Sølling ASK, Tougaard BG, Harsløf T, Langdahl B, Brockstedt HK, Byg KE, Ivarsen P, Ystrøm IK, Mose FH, Isaksson GL, Hansen MSS, Nagarajah S, Ejersted C, Bendstrup E, Rejnmark L.

Eur J Endocrinol. 2018 Jun;178(6):K29-K37. doi: 10.1530/EJE-18-0051. Epub 2018 Mar 29.

PMID:
29599408
13.

Indications of Increased Vertebral Fracture Risk in Patients With Type 2 Diabetes.

Starup-Linde J, Hygum K, Harsløf T, Langdahl BL.

J Bone Miner Res. 2018 Jan;33(1):182. doi: 10.1002/jbmr.3323. Epub 2017 Nov 30. No abstract available.

14.

Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats.

Ornstrup MJ, Brüel A, Thomsen JS, Harsløf T, Langdahl BL, Pedersen SB.

Calcif Tissue Int. 2018 Mar;102(3):337-347. doi: 10.1007/s00223-017-0344-6. Epub 2017 Oct 20.

PMID:
29058054
15.

Health-Related Quality of Life in Adults with Osteogenesis Imperfecta.

Hald JD, Folkestad L, Harsløf T, Brixen K, Langdahl B.

Calcif Tissue Int. 2017 Nov;101(5):473-478. doi: 10.1007/s00223-017-0301-4. Epub 2017 Jul 4.

PMID:
28676897
16.

MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.

Hygum K, Starup-Linde J, Harsløf T, Vestergaard P, Langdahl BL.

Eur J Endocrinol. 2017 Mar;176(3):R137-R157. doi: 10.1530/EJE-16-0652. Review.

PMID:
28049653
17.

Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism.

Harslof T, Sikjaer T, Mosekilde L, Langdahl BL, Rejnmark L.

Int J Endocrinol Metab. 2016 Aug 17;14(3):e38440. eCollection 2016 Jul.

18.

Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women.

Rønn SH, Harsløf T, Pedersen SB, Langdahl BL.

Eur J Endocrinol. 2016 Dec;175(6):541-549. Epub 2016 Sep 13.

PMID:
27625301
19.

Variations of SOST mRNA expression in human bone are associated with DNA polymorphism and DNA methylation in the SOST gene.

Lhaneche L, Hald JD, Domingues A, Hannouche D, Delepine M, Zelenika D, Boland A, Ostertag A, Cohen-Solal M, Langdahl BL, Harsløf T, de Vernejoul MC, Geoffroy V, Jehan F.

Bone. 2016 Nov;92:107-115. doi: 10.1016/j.bone.2016.08.004. Epub 2016 Aug 9.

PMID:
27519970
20.

Resveratrol Increases Osteoblast Differentiation In Vitro Independently of Inflammation.

Ornstrup MJ, Harsløf T, Sørensen L, Stenkjær L, Langdahl BL, Pedersen SB.

Calcif Tissue Int. 2016 Aug;99(2):155-63. doi: 10.1007/s00223-016-0130-x. Epub 2016 Mar 21.

PMID:
27000750
21.

New horizons in osteoporosis therapies.

Harsløf T, Langdahl BL.

Curr Opin Pharmacol. 2016 Jun;28:38-42. doi: 10.1016/j.coph.2016.02.012. Epub 2016 Mar 15. Review.

PMID:
26989807
22.

Hypercalcemia in metastatic GIST caused by systemic elevated calcitriol: a case report and review of the literature.

Hygum K, Wulff CN, Harsløf T, Boysen AK, Rossen PB, Langdahl BL, Safwat AA.

BMC Cancer. 2015 Oct 24;15:788. doi: 10.1186/s12885-015-1823-7. Review.

23.

The Effect of Treatment With PTH on Undercarboxylated Osteocalcin and Energy Metabolism in Hypoparathyroidism.

Harsløf T, Sikjær T, Sørensen L, Pedersen SB, Mosekilde L, Langdahl BL, Rejnmark L.

J Clin Endocrinol Metab. 2015 Jul;100(7):2758-62. doi: 10.1210/jc.2015-1477. Epub 2015 May 8.

PMID:
25955226
24.

Adipose tissue, estradiol levels, and bone health in obese men with metabolic syndrome.

Ornstrup MJ, Kjær TN, Harsløf T, Stødkilde-Jørgensen H, Hougaard DM, Cohen A, Pedersen SB, Langdahl BL.

Eur J Endocrinol. 2015 Feb;172(2):205-16. doi: 10.1530/EJE-14-0792. Epub 2014 Nov 21.

PMID:
25416724
25.

Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial.

Ornstrup MJ, Harsløf T, Kjær TN, Langdahl BL, Pedersen SB.

J Clin Endocrinol Metab. 2014 Dec;99(12):4720-9. doi: 10.1210/jc.2014-2799.

PMID:
25322274
26.

Rosiglitazone decreases bone mass and bone marrow fat.

Harsløf T, Wamberg L, Møller L, Stødkilde-Jørgensen H, Ringgaard S, Pedersen SB, Langdahl BL.

J Clin Endocrinol Metab. 2011 May;96(5):1541-8. doi: 10.1210/jc.2010-2077. Epub 2011 Mar 2.

PMID:
21367933
27.

Medical treatment of osteoporotic vertebral fractures.

Langdahl BL, Harsløf T.

Ther Adv Musculoskelet Dis. 2011 Feb;3(1):17-29. doi: 10.1177/1759720X10392105.

Supplemental Content

Loading ...
Support Center